1E Therapeutics is a startup based in Israel, most recent round Seed, 1 tracked investor.
1E Therapeutics is a company founded in 2018 headquartered in Israel. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Develops programmable oligonucleotide therapeutics that autonomously silence disease-causing RNAs in human or pathogen cells, targeting genetically driven diseases, chronic conditions, and multidrug-resistant infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.